Archive for May 2021
MediBeacon’s Start At the Helix Center
39 North‘s Helix Center Biotech Incubator, part of the St. Louis Economic Development Partnership (STL Partnership), is a destination location for bioscience, agricultural technology and plant science startups. Clients have…
Read More(St. Louis Business Journal) Agtech expertise draws millions in plant-based foods investments into St. Louis
That the region’s most promising agtech firm, Benson Hill — which has snagged more than $280 million in venture funding — is targeting the plant-based sector is emblematic of why…
Read More(St. Louis Business Journal) St. Louis agtech startup CoverCress, as it gears up for commercial launch, names new CE
St. Louis agtech startup CoverCress has a new leader at the top. CoverCress said Thursday it has named Mike DeCamp as president and CEO. He will also join the startup’s board of…
Read More(St. Louis Post Dispatch) Ag firm’s billion-dollar success validates St. Louis’ two-decade-old biotech vision
As the 20th century wound down, St. Louis had an identity crisis. The giant companies that had powered the economy for decades were running out of steam and being sold.…
Read MoreSTL Made Galera Therapeutics’ Stock Rises Following Positive Study for Experimental Cancer Therapy
Biopharmaceutical company Galera Therapeutics‘ stock price rose 41% after showing results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company is creating proprietary therapies that can…
Read MoreBENSON HILL – SUSTAINABLE FOOD TECHNOLOGY COMPANY DRIVING THE PLANT-BASED FOOD REVOLUTION – TO COMBINE WITH STAR PEAK CORP II
Benson Hill, a food technology company unlocking the natural genetic diversity of plants, announced today that it will become publicly listed through a business combination with Star Peak Corp II…
Read MoreSt. Louis-born Galera’s stock soars after release of positive study data for its experimental cancer therapy
Galera Therapeutics‘ stock price jumped 41% Thursday morning after the St. Louis-born biopharmaceutical company provided updated results from early-stage testing of its experimental therapy for advanced pancreatic cancer. READ MORE.
Read More